State legislatures across the country have introduced bills designed to regulate the use of artificial intelligence (AI) systems by health care entities.
AMCP Comment Letter on Biosimilar Interchangeability with a Biologic Reference Product
On Aug. 6, AMCP responded to FDA’s draft guidance on considerations in demonstrating biosimilar interchangeability with a biologic reference product. The draft guidance, issued on June 17, describes considerations regarding switching studies which demonstrate interchangeability between biosimilars and their reference biologic products.
Related
Today, the Congressional Budget Office (CBO) released an updated cost estimate for the One Big, Beautiful Bill Act (H.R. 1). This cost estimate incorporates the amendments made to H.R. 1 in the hours before the House passed the legislation by a vote of 215-214-1.
Academy of Managed Care Pharmacy (AMCP) issued a statement from CEO Susan A. Cantrell, MHL, RPh, CAE, following passage of the budget reconciliation bill that includes large-scale changes to Medicaid, the Affordable Care Act (ACA), Grad PLUS loans, and other programs.
Featured News & Resources
See Full Calendar
National Meetings
Midwest AMCP Chicago Day of Education
National Meetings
Mountain West Pharmacy Summit
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
